Human skin has a distinct profile of fatty acids and related bioactive lipid mediators that regulate many aspects of epidermal and dermal homeostasis, including immune and inflammatory reactions. Sebum lipids act as effective antimicrobial agents, shape immune cell communications and contribute to the epidermal lipidome. The essential fatty acid linoleic acid is crucial for the structure of the epidermal barrier, while polyunsaturated fatty acids act as precursors to eicosanoids, octadecanoids and docosanoids through cyclooxygenase, lipoxygenase and cytochrome P450 monooxygenase-mediated reactions, and endocannabinoids and N-acyl ethanolamines. Cross-communication between these families of bioactive lipids suggests that their cutaneous activities should be considered as part of a wider metabolic network that can be targeted to maintain skin health, control inflammation and improve skin pathologies.
INTRODUCTION
Fatty acids have long been recognised for their importance in skin health, and essential fatty acid deficiencies result in fatal epidermal barrier failure, characterised by desquamation and skin lesions (1, 2) . Altering the cutaneous fatty acid profile through diet or nutritional supplementation has been reported to ameliorate inflammatory conditions [reviewed in (3) (4) (5) (6) ]. As well as having direct effects on signalling pathways, gene transcription, inflammatory and immune responses, many of the fatty acid-mediated bioactivities are attributed, at least in part, to the formation of bioactive derivatives. These lipid mediators are produced via sequential enzymatic reactions that typically start with the liberation of the relevant fatty acid precursor from membrane phospholipids, following the action of inflammatory or other stimuli that activate the relevant phospholipases (7) (8) (9) . Once cleaved from the cellular membranes, free fatty acids can be converted into an array of bioactive mediators following the action of prostaglandin-endoperoxide synthases (cyclooxygenases; COX), lipoxygenases (LOX) and cytochrome P450 monooxygenases (CYP), as well as transcellular and non-enzymatic reactions. Figure 1 shows a diagrammatic outline of the main biochemical reactions mediating the biotransformation of the key polyunsaturated fatty acid (PUFA) arachidonic acid (AA; C20:4n-6). The metabolism of various cutaneous PUFA occurs in a similar way, and results in an array of eicosanoids, docosanoids, octadecanoids, endocannabinoids and N-acyl ethanolamines (NAE), that have all been implicated in numerous aspects of cutaneous inflammation (3, 5) . This review article aims to give an overview of the most important fatty acids that are found in human skin, discuss their properties, and introduce the biochemical pathways leading to the formation of bioactive lipid mediators involved in skin cell biology. A detailed appreciation of the profiles and balance of cutaneous fatty acids and related metabolites is important as this system can be targeted to maintain skin health, regulate inflammation, and improve skin pathologies.
CUTANEOUS FATTY ACIDS

SEBUM FATTY ACIDS
Human sebum has a unique fatty acid profile that contains the sebum-characteristic sapienic acid (C16:1n-10), as well as palmitic acid (PA; C16:0), palmitoleic acid (C16:1n-7), and oleic acid (OA; C18:1n-9) (10-12). Importantly, sebum-derived fatty acids have been shown to be effective antimicrobial agents for bacteria such as Porphyromonas gingivalis, Staphylococcus aureus and Staphylococcus epidermidis, and play an active role in shaping the cutaneous microbiome (11) (12) (13) (14) (15) (16) . They are also actively involved in epidermal homeostasis and immune cell communications. It has been shown that OA can alter intracellular calcium in normal human keratinocytes and murine skin, leading to hyperproliferation and increased trans-epidermal water loss, while palmitoleic acid can cause keratinocyte hyperplasia in mouse skin (17, 18) . Overall, sebum fatty acids contribute significantly to skin health and epidermal defence functions (16, 19) , directly affecting epidermal keratinocytes, informing the cutaneous immune barrier, and protecting the surface of the skin from pathogenic microorganisms.
FATTY ACIDS IN EPIDERMIS AND DERMIS
Cutaneous fatty acids found in the epidermis and dermis are key determinants of skin health.
The epidermis is the outermost skin layer and comprises a basal layer of proliferating keratinocytes, which switch to differentiate and migrate upwards to form multiple stratified layers of denucleated cells at the surface (19) . The most abundant fatty acids in this layer are saturated fatty acids (SFA) i.e. PA and stearic acid, and monounsaturated fatty acids (MUFA) such as OA (~23% each) (20) . The dermis contains high levels of unsaturated fatty acids, mostly OA (~45%), as well as the SFA PA (~20%) (20) . The ratio between SFA and MUFA represents the activity of Δ9 desaturase, an enzyme important for skin health: inhibition of Δ9 desaturase was shown to reduce proliferation of dermal fibroblasts and disturb the cellular response to growth factors, whilst deletion of the Δ9 desaturase gene in an animal model resulted in a ulcerative dermatitis, dry, flaky skin and severe alopecia (21) (22) (23) .
Polyunsaturated fatty acids (PUFA) are found at lower levels than SFA or MUFA, e.g. linoleic acid (LA; C18:2n-6) and AA comprise approximately 9-10 % and 2-3 % of the epidermal fatty acids, respectively. However, PUFA are very important for skin health [reviewed in (20) ].
Linoleic acid is an essential fatty acid, an integral component of acylceramides, and insufficient levels result in impaired formation of the epidermal permeability barrier (24, 25) .
Indeed, genetic abnormalities in elongase enzymes (for example ELOV4 deficiency), render the skin unable to produce long chain fatty acids, and the barrier fails due to an absence of acylceramides (26) . Additionally, the epidermis relies on the dermis and systemic supplementation to provide long chain PUFA such as AA, eicosapentaenoic acid (EPA; C20:5n-3) and docosahexaenoic acid (DHA; C22:6n-3), as it lacks the necessary 5 and 6 desaturases to form these long chain PUFA from C18 fatty acid precursors (27) . Thus the cutaneous profile of these fatty acids is greatly influenced by diet, and responds to nutritional supplementation (4, 5, 28) . Animal and clinical studies, as well as work with preclinical models, have shown that PUFA supplementation can confer photoprotection, improve wound healing and reduce inflammatory markers (4, 29, 30) . Although the detailed molecular mechanisms of how fatty acids influence skin health are not always understood, often their effects can be attributed to formation of bioactive metabolites, as discussed below.
FATTY ACID-DERIVED LIPID MEDIATORS
PROSTANOIDS
The family of prostanoids includes various prostaglandins (PG), thromboxanes (TX) and prostacyclin (PGI 2 ), all formed from 20-carbon PUFA precursors (i.e. AA, dihomo-gamma linolenic acid (DGLA; C18:3n-6) and EPA), through the activities of constitutive COX-1 and/or inducible COX-2, and terminal prostanoid synthases (Figure 1) . The bioactivities of prostanoids are mediated though a series of G protein coupled receptors that have been identified in many cell types, including skin cells [reviewed in (3, 5, 7) ].
Keratinocytes and fibroblasts, as well as skin-resident immune cells, produce a number of prostanoids including PGE 2 , PGE 1 , PGE 3 , PGD 2 , PGF 2 , PGI 2 , and TXB 2 (31) (32) (33) . One of the best studied species is PGE 2 , which regulates keratinocyte and fibroblast growth and proliferation through production of growth factors and cytokines, including fibroblast growth factor, epidermal growth factor (EGF), tumour necrosis factor-α, interleukin (IL) -1, IL-6 and IL-8 (34) (35) (36) (37) (38) (39) . PGE 2 also acts as a potent immunomodulatory stimulus, triggering recruitment of T lymphocytes and maturation of dendritic cells, both important for skin immunity (40) (41) (42) .
These changes are associated with vasodilation and further recruitment of immune cells, as demonstrated by the increased accumulation of neutrophils and oedema in rodent skin following a local injection of PGE 1 and PGE 2 (43, 44) . Conversely, PGE 3 was not mitogenic in murine epidermal cultures or a dermal fibroblast cell line, and it has been suggested to play an anti-inflammatory role (45) (46) (47) .
PGD 2 can also stimulate T-cell and eosinophil migration (48) . In skin, it is produced mainly by Langerhans cells and dermal mast cells, and high levels of PGD 2 have been linked to hair loss and androgenetic alopecia (49) . The inhibition of hair growth involves a potent apoptotic action of PGD 2 on follicular keratinocytes, although it has also been shown that PGD 2 may also act as an anti-inflammatory mediator, depending on the cell type and time of its production (50) .
Multiple studies have shown increased production of cutaneous prostanoids following the upregulation of COX-2 in response to inflammatory stimuli, as observed in the sunburn reaction and wound healing (33, 51, 52) . Interestingly, COX-2 inhibitors were found to cause a significant delay to wound healing, with wounds showing significant reduction in PGE 2 levels, epidermal proliferation, angiogenesis and extracellular matrix (53, 54) . However, mice showed accelerated wound healing when catabolism of PGE 2 was inhibited (55, 56) . This finding highlights the role of skin prostaglandins in regulating the early phases of inflammation, which are crucial for efficient resolution and tissue remodelling. Non-steroidal anti-inflammatory drugs inhibit COX-1 and -2 activity, and therefore prostanoid production, which may reduce skin inflammation. However free fatty acids are then metabolised through other enzyme pathways. Indeed, when cutaneous COX-derived prostaglandin production was blocked by indomethacin, LOX metabolism dominated and an increase in 12hydroxyeicosatetraenoic acid (HETE) was observed, so although erythema was reduced, there was a greater inflammatory infiltrate in the skin (57) . Interestingly, PGE 2 has recently been shown to mediate a phase of post-inflammatory immune-suppression, believed to be important for prevention of an autoimmune response, highlighting its importance past the initial inflammatory phase (58).
HYDROXY FATTY ACIDS
Lipoxygenases (LOX) produce a series of hydroxy fatty acids and leukotrienes (LT) (59, 60) . (Figure 1) . The 12R-LOX is unique to mammalian skin cells and has been purported to be involved in cutaneous inflammation, given observations of 12R-HETE in psoriasis skin. Its main role, however, is believed to be linked to the formation of the epidermal lipid barrier, in conjunction with the epidermis-type eLOX-3. These two enzymes perform consecutive oxidisations of the linoleic acid in acylceramides, enabling its linkage to cornified envelope proteins, which is crucial for an effective epidermal barrier (60) (61) (62) (63) .
Indeed, congenital ichthyosis has been linked to mutations in 12R LOX and eLOX-3 (64, 65) .
LOX reactions are also involved in the transcellular metabolism of PUFA to generate lipoxins from AA, resolvins and protectins from EPA and DHA, and maresins from DHA, collectively known as specialised pro-resolving mediators (SPMs) for their anti-inflammatory functions (66) . Although a number of their hydroxy fatty acid precursors have been found in skin, before and after PUFA supplementation, the SPMs themselves have not been identified in skin to-date, and their importance in cutaneous health and disease remains unclear (29, 67, 68) .
Linoleic acid-derived hydroxyoctadecadienoic acids (HODE) are the most abundant hydroxy fatty acids found in human skin (20) . (83) . Interestingly, a study on mice lacking the 12/15LOX gene showed a reduced number of mesenchymal stem cells with disturbed kinetics in the wounded dermis, which has implications for tissue remodelling (84) . Additionally, the 12-LOX DHA product, 14-HDHA improved all stages of the wound healing process in mice, via enhanced reepithelization, granulation and angiogenesis (85) . Hence, these findings confirm a strong involvement of LOX-derived PUFA mediators in sustaining the later stages of inflammation, when COX-mediated production of prostaglandins has decreased (33).
EPOXY FATTY ACIDS
The cytochrome P450 (CYP) isozymes CYP2C and CYP2J are epoxygenases that mediate the production of epoxyeicosatrienoic acids (EET) from AA (Figure 1) . 
ENDOCANNABINOIDS AND N-ACYL ETHANOLAMINES
Human skin produces the classic endocannabinoids arachidonoyl ethanolamine (anandamide; AEA) and 2-arachidonoyl glycerol (2-AG)), as well as a range of N-acyl ethanolamines (NAE) (20) (Figure 1) . AEA and 2-AG are known ligands for the cannabinoid receptors CB1 and CB2, the expression of which has been reported in the epidermis, dermoepidermal junction and dermis (20, 99) . AEA and 2-AG derive from phospholipid-esterified arachidonic acid, and can be further metabolised by COX, LOX and CYP enzymes, however the prevalence of these species in human skin has not been confirmed (9) . Many of the fatty acid-derived NAE present very low or no affinity to CB1 or CB2, and are believed to act through other receptors such as vanilloid receptor 1 (TRPV1) and PPARα (100, 101) .
Endocannabinoids and NAE are involved in various cutaneous functions, including keratinocyte differentiation (102, 103) . AEA inhibits the proliferation of human epidermal keratinocytes and dermal fibroblasts via induction of apoptosis (103, 104) . This apoptotic function of AEA was also observed in human sebocytes, where both AEA and 2-AG stimulated differentiation, maturation and lipogenesis via CB2-mediated signalling (105, 106) . Furthermore, AEA limits excessive mast cell activation in hair follicles, highlighting its function in the regulation of dermal inflammation (107) . suggesting a potentially important role in skin (112) (113) (114) .
Endocannabinoids and NAEs may also serve as immunomodulatory mediators in the skin, and have been found to be upregulated during various types of skin inflammation (99, 115) .
AEA and 2-AG levels were increased after UVR treatment of HaCaT keratinocytes (116) , while in study involving different keratinocyte and fibroblast cell lines, AEA, 2-AG and CB1
and CB2 expression were found to decrease following UVR irradiation (117, 118) . A clinical study (119) reported increased 2-AG but stable levels of AEA, OEA and PEA in the serum of human volunteers subjected to a repetitive cutaneous exposure to simulated solar UVR (119) . Similarly, the skin of human volunteers irradiated with low-dose UVR did not show any changes in levels of endocannabinoids and NAE species, although there was an increase of stearoyl ethanolamine, LEA, OEA and PEA following sodium lauryl sulfate application (120) .
Mustard vesicants also increased levels of AEA and 2-AG, and increased expression of CB receptors, in murine skin in vivo, although only several days after stimulation (121) .
Overall, it is believed that endocannabinoids and NAE may act to quench inflammation, and their production may prevent an excessive inflammatory response in the skin. Upregulation of CB1/CB2 receptor expression was observed in fibroblasts and macrophage-like cells during wound healing in rats (104), while 2-AG and CB1 activation are associated with reduced immune infiltration, scarring and accelerated wound closure in epithelial cells.
However, CB1 activation in the dermis slowed wound healing, suggesting different roles for endocannabinoids in the different skin compartments (104, 122) . 
CONCLUSION
